NDC 63539-502 – Xeljanz Xr
Tofacitinib Citrate 22 mg/1 · Tablet, Extended Release · Oral
Product NDC63539-502
Product details
- Brand name
- Xeljanz Xr
- Generic name
- Tofacitinib
- Labeler
- U.S. Pharmaceuticals
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- NDA · NDA208246
- Marketed since
- January 21, 2020
- Listing expires
- December 31, 2027
- Pharmacologic class
- Janus Kinase Inhibitor
Active ingredients
- Tofacitinib Citrate 22 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 63539-502-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63539-502-30) | Jan 21, 2020 |
Other Xeljanz products
- 63539-501 Tofacitinib Citrate 11 mg/1 · Tablet, Extended Release · U.S. Pharmaceuticals
- 0069-0501 Tofacitinib Citrate 11 mg/1 · Tablet, Film Coated, Extended Release · Pfizer Laboratories Div Pfizer Inc
- 0069-0502 Tofacitinib Citrate 22 mg/1 · Tablet, Film Coated, Extended Release · Pfizer Laboratories Div Pfizer Inc
- 0069-1001 Tofacitinib Citrate 5 mg/1 · Tablet, Film Coated · Pfizer Laboratories Div Pfizer Inc
- 0069-1002 Tofacitinib Citrate 10 mg/1 · Tablet, Film Coated · Pfizer Laboratories Div Pfizer Inc
- 0069-1029 Tofacitinib Citrate 1 mg/mL · Solution · Pfizer Laboratories Div Pfizer Inc
- 63539-012 Tofacitinib Citrate 5 mg/1 · Tablet, Film Coated · U.S. Pharmaceuticals
- 63539-016 Tofacitinib Citrate 10 mg/1 · Tablet, Film Coated · U.S. Pharmaceuticals
- 63539-029 Tofacitinib Citrate 1 mg/mL · Solution · U.S. Pharmaceuticals